- Raised grant, Aug 2017
- Raised funding round, Jun 2017
- Raised grant, Jul 2015
About
Innovo Mimetics specializes in anti-cancer therapy efficacy assays in the well-established chick egg tumor xenograft model. This model is based on the ability of a fertilized chick egg to engraft and nourish foreign cells, including cancer cells, that are placed in the egg. Innovo's proprietary assay system, ScreenOvo, allows rapid and low-cost evaluation of chemical, biological, and cell therapies. The advantages of the ScreenOvo Assay include a living tumor at low cost; a complete assay in 14 days; and broad applicability for testing immune cell therapies, checkpoint inhibition, and anti-cancer drug efficacy. ScreenOvo is designed as a service tool for immunotherapy and pharmaceutical companies to deliver xenograft tumor data in the chick egg model in order to expand the cancer therapy pipeline, generate proofs of concept for new innovations, screen for lead products, and reduce research risk before heavily investing in mouse models. ScreenOvo offers cancer cell recognition and killing, tumor infiltration, antibody-dependent cellular cytotoxicity, and checkpoint inhibition.
Funding history · 4 rounds · $160K total
Q&A
- What is Innovo Mimetics' primary focus?
- Innovo Mimetics specializes in anti-cancer therapy efficacy assays using a chick egg tumor xenograft model.
- What is the status of Innovo Mimetics?
- Innovo Mimetics is currently inactive, having ceased operations in December 2024.
- When was Innovo Mimetics founded?
- Innovo Mimetics was founded in March 2010.
- What is Innovo Mimetics' proprietary assay system called?
- Innovo Mimetics' proprietary assay system is called ScreenOvo.
- What are the key advantages of the ScreenOvo Assay?
- The ScreenOvo Assay offers a living tumor at low cost, completes an assay in 14 days, and is broadly applicable for testing immune cell therapies, checkpoint inhibition, and anti-cancer drug efficacy.
- Who is the founder and CEO of Innovo Mimetics?
- Jonathan Goldstein is the Founder & CEO of Innovo Mimetics.
- How many employees does Innovo Mimetics have?
- Innovo Mimetics has 1-10 employees.
- What is the total amount raised by Innovo Mimetics?
- Innovo Mimetics has raised a total of $160,000 USD.
- When did Innovo Mimetics receive its last grant?
- Innovo Mimetics received a grant in August 2017 from the Israel Innovation Authority.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2010-3 |
|---|---|
| Employees (exact) | 8 |
| Status reason | Non Active, Dec 2024 ceased to operate |